This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
SB70-AA3,115,14 13(6) Rulemaking. The commissioner may promulgate any rules necessary to
14implement this section.
SB70-AA3,131 15Section 131. 601.59 of the statutes is created to read:
SB70-AA3,115,16 16601.59 State-based exchange. (1) Definitions. In this section:
SB70-AA3,115,1717 (a) “Exchange” has the meaning given in 45 CFR 155.20.
SB70-AA3,115,2018 (b) “State-based exchange on the federal platform” means an exchange that is
19described in and meets the requirements of 45 CFR 155.200 (f) and is approved by
20the federal secretary of health and human services under 45 CFR 155.106.
SB70-AA3,115,2421 (c) “State-based exchange without the federal platform” means an exchange,
22other than one described in 45 CFR 155.200 (f), that performs all the functions
23described in 45 CFR 155.200 (a) and is approved by the federal secretary of health
24and human services under 45 CFR 155.106.
SB70-AA3,116,7
1(2) Establishment and operation of state-based exchange. The commissioner
2shall establish and operate an exchange that at first is a state-based exchange on
3the federal platform and then subsequently transitions to a state-based exchange
4without the federal platform. The commissioner shall develop procedures to address
5the transition from the state-based exchange on the federal platform to the
6state-based exchange without the federal platform, including the circumstances
7that shall be met in order for the transition to occur.
SB70-AA3,116,10 8(3) Agreement with federal government. The commissioner may enter into
9any agreement with the federal government necessary to facilitate the
10implementation of this section.
SB70-AA3,116,16 11(4) User fees. The commissioner shall impose a user fee, as authorized under
1245 CFR 155.160 (b) (1), on each insurer that offers a health plan through the
13state-based exchange on the federal platform or the state-based exchange without
14the federal platform. The user fee shall be applied at one of the following rates on
15the total monthly premiums charged by an insurer for each policy under the plan for
16which enrollment is through the exchange:
SB70-AA3,116,1817 (a) For any plan year for which the commissioner operates a state-based
18exchange on the federal platform, the rate is 0.5 percent.
SB70-AA3,116,2219 (b) For the first 2 plan years for which the commissioner operates a state-based
20exchange without the federal platform, the rate is equal to the user fee rate the
21federal department of health and human services specifies under 45 CFR 156.50 (c)
22(1) for the federally facilitated exchanges for the applicable plan year.
SB70-AA3,116,2523 (c) Beginning with the 3rd plan year for which the commissioner operates a
24state-based exchange without the federal platform and for each plan year thereafter,
25the rate shall be set by the commissioner by rule.
SB70-AA3,117,2
1(5) Rules. The commissioner may promulgate rules necessary to implement
2this section.
SB70-AA3,132 3Section 132. 601.83 (1) (h) of the statutes is renumbered 601.83 (1) (h) (intro.)
4and amended to read:
SB70-AA3,117,105 601.83 (1) (h) (intro.) In 2019 and in each subsequent year Unless the joint
6committee on finance under s. 13.10 increases the amount upon request by the
7commissioner
, the commissioner may expend no more than $200,000,000 the
8following amounts
from all revenue sources for the healthcare stability plan under
9this section, unless the joint committee on finance under s. 13.10 has increased this
10amount upon request by the commissioner.
:
SB70-AA3,117,14 11(he) The commissioner shall ensure that sufficient funds are available for the
12healthcare stability plan under this section to operate as described in the approval
13of the federal department of health and human services dated July 29, 2018, and in
14any waiver extension approvals
.
SB70-AA3,133 15Section 133. 601.83 (1) (h) 1. and 3. of the statutes are created to read:
SB70-AA3,117,1616 601.83 (1) (h) 1. In 2019, 2020, and 2021, $200,000,000.
SB70-AA3,117,2517 3. In 2025 and in each year thereafter, the maximum expenditure amount for
18the previous year, adjusted to reflect the percentage increase, if any, in the consumer
19price index for all urban consumers, U.S. city average, for the medical care group, as
20determined by the U.S. department of labor, for the 12-month period ending on
21December 31 of the year before the year in which the amount is determined. The
22commissioner shall determine the annual adjustment amount for a particular year
23in January of the previous year. The commissioner shall publish the new maximum
24expenditure amount under this subdivision each year in the Wisconsin
25Administrative Register.
SB70-AA3,134
1Section 134. 601.83 (1) (hm) of the statutes is renumbered 601.83 (1) (h) 2. and
2amended to read:
SB70-AA3,118,53 601.83 (1) (h) 2. Notwithstanding par. (h), in In 2022 and in each year
4thereafter, the commissioner may expend from all revenue sources
, 2023, and 2024,
5$230,000,000 or less for the healthcare stability plan under this section.
SB70-AA3,135 6Section 135. 609.714 of the statutes is created to read:
SB70-AA3,118,9 7609.714 Substance abuse counselor coverage. Limited service health
8organizations, preferred provider plans, and defined network plans are subject to s.
9632.87 (8).
SB70-AA3,136 10Section 136. 609.719 of the statutes is created to read:
SB70-AA3,118,13 11609.719 Coverage for telehealth services. Limited service health
12organizations, preferred provider plans, and defined network plans are subject to s.
13632.871.
SB70-AA3,137 14Section 137. 609.83 of the statutes is amended to read:
SB70-AA3,118,18 15609.83 Coverage of drugs and devices ; application of payments.
16Limited service health organizations, preferred provider plans, and defined network
17plans are subject to ss. 632.853, 632.861, 632.862, and 632.895 (6) (b), (16t), and
18(16v).
SB70-AA3,138 19Section 138. 628.495 of the statutes is created to read:
SB70-AA3,118,22 20628.495 Pharmacy benefit management broker and consultant
21licenses.
(1) Definition. In this section, “pharmacy benefit manager” has the
22meaning given in s. 632.865 (1) (c).
SB70-AA3,119,2 23(2) License required. Beginning on the first day of the 12th month beginning
24after the effective date of this subsection .... [LRB inserts date], no individual may
25act as a pharmacy benefit management broker or consultant or any other individual

1who procures the services of a pharmacy benefit manager on behalf of a client
2without being licensed by the commissioner under this section.
SB70-AA3,119,5 3(3) Rules. The commissioner may promulgate rules to establish criteria and
4procedures for initial licensure and renewal of licensure and to implement licensure
5under this section.
SB70-AA3,139 6Section 139. 632.7495 (4) (b) of the statutes is amended to read:
SB70-AA3,119,77 632.7495 (4) (b) The coverage has a term of not more than 12 3 months.
SB70-AA3,140 8Section 140. 632.7495 (4) (c) of the statutes is amended to read:
SB70-AA3,119,139 632.7495 (4) (c) The coverage term aggregated with all consecutive periods of
10the insurer's coverage of the insured by individual health benefit plan coverage not
11required to be renewed under this subsection does not exceed 18 6 months. For
12purposes of this paragraph, coverage periods are consecutive if there are no more
13than 63 days between the coverage periods.
SB70-AA3,141 14Section 141. 632.7496 of the statutes is created to read:
SB70-AA3,119,17 15632.7496 Coverage requirements for short-term plans. (1) Definition.
16In this section, “short-term, limited duration plan” means an individual health
17benefit plan described in s. 632.7495 (4).
SB70-AA3,119,20 18(2) Guaranteed issue. An insurer that offers a short-term, limited duration
19plan shall accept every individual in this state who applies for coverage regardless
20of whether the individual has a preexisting condition.
SB70-AA3,120,2 21(3) Prohibiting discrimination based on health status. (a) An insurer that
22offers a short-term, limited duration plan may not establish rules for the eligibility
23of any individual to enroll, or for the continued eligibility of any individual to remain
24enrolled, under a short-term, limited duration plan based on any of the following

1health status-related factors with respect to the individual or a dependent of the
2individual:
SB70-AA3,120,33 1. Health status.
SB70-AA3,120,44 2. Medical condition, including both physical and mental illnesses.
SB70-AA3,120,55 3. Claims experience.
SB70-AA3,120,66 4. Receipt of health care.
SB70-AA3,120,77 5. Medical history.
SB70-AA3,120,88 6. Genetic information.
SB70-AA3,120,109 7. Evidence of insurability, including conditions arising out of acts of domestic
10violence.
SB70-AA3,120,1111 8. Disability.
SB70-AA3,120,1912 (b) An insurer that offers a short-term, limited duration plan may not require
13any individual, as a condition of enrollment or continued enrollment under the
14short-term, limited duration plan, to pay, on the basis of any health status-related
15factor described under par. (a) with respect to the individual or a dependent of the
16individual, a premium or contribution or a deductible, copayment, or coinsurance
17amount that is greater than the premium or contribution or deductible, copayment,
18or coinsurance amount respectively for a similarly situated individual enrolled
19under the short-term, limited duration plan.
SB70-AA3,120,22 20(4) Premium rate variation. An insurer that offers a short-term, limited
21duration plan may vary premium rates for a specific short-term, limited duration
22plan based only on the following considerations:
SB70-AA3,120,2423 (a) Whether the short-term, limited duration plan covers an individual or a
24family.
SB70-AA3,120,2525 (b) Rating area in the state, as established by the commissioner.
SB70-AA3,121,3
1(c) Age, except that the rate may not vary by more than 3 to 1 for adults over
2the age groups and the age bands shall be consistent with recommendations of the
3National Association of Insurance Commissioners.
SB70-AA3,121,44 (d) Tobacco use, except that the rate may not vary by more than 1.5 to 1.
SB70-AA3,121,6 5(5) Annual and lifetime limits. A short-term, limited duration plan may not
6establish any of the following:
SB70-AA3,121,87 (a) Lifetime limits on the dollar value of benefits for an enrollee or a dependent
8of an enrollee under the short-term, limited duration plan.
SB70-AA3,121,119 (b) Limits on the dollar value of benefits for an enrollee or a dependent of an
10enrollee under the short-term, limited duration plan for a term of coverage or for the
11aggregate duration of the short-term, limited duration plan.
SB70-AA3,142 12Section 142. 632.76 (2) (ac) 3. (intro.) of the statutes is amended to read:
SB70-AA3,121,1513 632.76 (2) (ac) 3. (intro.) Except as the commissioner provides by rule under
14s. 632.7495 (5), all of the following apply to an individual disability insurance policy
15that is a short-term policy, limited duration plan subject to s. 632.7495 (4) and (5):
SB70-AA3,143 16Section 143. 632.76 (2) (ac) 3. b. of the statutes is amended to read:
SB70-AA3,121,2217 632.76 (2) (ac) 3. b. The policy shall reduce the length of time during which a
18may not impose any preexisting condition exclusion may be imposed by the
19aggregate of the insured's consecutive periods of coverage under the insurer's
20individual disability insurance policies that are short-term policies subject to s.
21632.7495 (4) and (5). For purposes of this subd. 3. b., coverage periods are consecutive
22if there are no more than 63 days between the coverage periods
.
SB70-AA3,144 23Section 144. 632.862 of the statutes is created to read:
SB70-AA3,121,25 24632.862 Application of prescription drug payments. (1) Definitions. In
25this section:
SB70-AA3,122,1
1(a) “Brand name” has the meaning given in s. 450.12 (1) (a).
SB70-AA3,122,22 (b) “Brand name drug” means any of the following:
SB70-AA3,122,43 1. A prescription drug that contains a brand name and that has no generic
4equivalent.
SB70-AA3,122,95 2. A prescription drug that contains a brand name and has a generic equivalent
6but for which the enrollee has received prior authorization from the insurer offering
7the disability insurance policy or self-insured health plan or authorization from a
8physician to obtain the prescription drug under the disability insurance policy or
9self-insured health plan.
SB70-AA3,122,1010 (c) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a).
SB70-AA3,122,1111 (d) “Prescription drug” has the meaning given in s. 450.01 (20).
SB70-AA3,122,1312 (e) “Self-insured health plan” means a self-insured health plan of the state or
13a county, city, village, town, or school district.
SB70-AA3,122,19 14(2) Application of discounts. A disability insurance policy that offers a
15prescription drug benefit or a self-insured health plan shall apply to any calculation
16of an out-of-pocket maximum amount and to any deductible of the disability
17insurance policy or self-insured health plan for an enrollee the amount that any
18discount provided by the manufacturer of a brand name drug reduces the cost
19sharing amount charged to the enrollee for that brand name drug.
SB70-AA3,145 20Section 145. 632.863 of the statutes is created to read:
SB70-AA3,122,21 21632.863 Pharmaceutical representatives. (1) Definitions. In this section:
SB70-AA3,122,2422 (a) “Health care professional” means a physician or other health care
23practitioner who is licensed to provide health care services or to prescribe
24pharmaceutical or biologic products.
SB70-AA3,123,2
1(b) “Pharmaceutical” means a medication that may legally be dispensed only
2with a valid prescription from a health care professional.
SB70-AA3,123,53 (c) “Pharmaceutical representative” means an individual who markets or
4promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical
5manufacturer for compensation.
SB70-AA3,123,12 6(2) Licensure. Beginning on the first day of the 12th month beginning after
7the effective date of this subsection .... [LRB inserts date], no individual may act as
8a pharmaceutical representative in this state without being licensed by the
9commissioner as a pharmaceutical representative under this section. In order to
10obtain a license, the individual shall apply to the commissioner in the form and
11manner prescribed by the commissioner. The term of a license issued under this
12subsection is one year and is renewable.
SB70-AA3,123,15 13(3) Display of license. A pharmaceutical representative licensed under sub.
14(2) shall display the pharmaceutical representative's license during each visit with
15a health care professional.
SB70-AA3,123,18 16(4) Enforcement. (a) Any individual who violates this section shall be fined
17not less than $1,000 nor more than $3,000 for each offense. Each day of continued
18violation constitutes a separate offense.
SB70-AA3,123,2219 (b) The commissioner may suspend or revoke the license of a pharmaceutical
20representative who violates this section. A suspended or revoked license may not be
21reinstated until the pharmaceutical representative remedies all violations related
22to the suspension or revocation and pays all assessed penalties and fees.
SB70-AA3,123,25 23(5) Rules. The commissioner shall promulgate rules to implement this section,
24including rules that require pharmaceutical representatives to complete continuing
25educational coursework as a condition of licensure.
SB70-AA3,146
1Section 146. 632.864 of the statutes is created to read:
SB70-AA3,124,3 2632.864 Pharmacy services administrative organizations. (1)
3Definitions. In this section:
SB70-AA3,124,44 (a) “Administrative service” means any of the following:
SB70-AA3,124,55 1. Assisting with claims.
SB70-AA3,124,66 2. Assisting with audits.
SB70-AA3,124,77 3. Providing centralized payment.
SB70-AA3,124,88 4. Performing certification in a specialized care program.
SB70-AA3,124,99 5. Providing compliance support.
SB70-AA3,124,1010 6. Setting flat fees for generic drugs.
Loading...
Loading...